ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 170 filers reported holding ARGENX SE in Q2 2020. The put-call ratio across all filers is 0.93 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,687,225 | -5.4% | 7,500 | -25.0% | 1.54% | +65.6% |
| Q2 2023 | $3,897,300 | +4.6% | 10,000 | 0.0% | 0.93% | -9.6% |
| Q1 2023 | $3,725,800 | -12.1% | 10,000 | -16.7% | 1.03% | -34.5% |
| Q3 2022 | $4,237,000 | +25.4% | 12,000 | -20.0% | 1.57% | +211.1% |
| Q2 2020 | $3,378,000 | -4.5% | 15,000 | -73.2% | 0.50% | -66.3% |
| Q4 2017 | $3,536,000 | +156.4% | 56,000 | -13.8% | 1.50% | +157.1% |
| Q2 2017 | $1,379,000 | – | 65,000 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |